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Abstract
Touch spray - mass spectrometry (TS-MS) is an ambient ionization technique (ionization of 
unprocessed samples in the open air) that may find intraoperative applications in quickly 
identifying the disease state of cancerous tissues and in defining surgical margins. In this study, 
TS-MS was performed on fresh kidney tissue (~1–5 cm3), within one hour of resection, from 21 
human subjects afflicted by renal cell carcinoma (RCC). The preliminary diagnostic value of TS-
MS data taken from freshly resected tissue was evaluated. Principal component analysis (PCA) of 
the negative ion mode (m/z 700–1000) data provided separation between RCC (16 samples) and 
healthy renal tissue (13 samples). Linear discriminant analysis (LDA) on the PCA compressed 
data estimated sensitivity (true positive rate) and specificity (true negative rate) of 98% and 95%, 
respectively, based on histopathological evaluation. The results indicate that TS-MS might provide 
rapid diagnostic information in spite of the complexity of unprocessed kidney tissue and the 
presence of interferences such as urine and blood. Desorption electrospray ionization imaging 
(DESI-MSI) in the negative ionization mode was performed on the tissue specimens after TS-MS 
analysis as a reference method. The DESI imaging experiments provided phospholipid profiles 
(m/z 700–1000) that also separated RCC and healthy tissue in the PCA space, with PCA-LDA 
sensitivity and specificity of 100% and 89%, respectively. The TS and DESI loading plots 
indicated that different ions contributed most to the separation of RCC from healthy renal tissue 
(m/z 794 [PC 34:1+Cl]− and 844 [PC 38:4+Cl]− for TS vs. m/z 788 [PS 36:1-H]− and 810 [PS 
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38:4-H]− for DESI), while m/z 885 ([PI 38:4-H]−) was important in both TS and DESI. The 
prospect, remaining hurdles, and future work required for translating TS-MS into a method of 
intraoperative tissue diagnosis is discussed.
Graphical abstract
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 Introduction
Kidney cancers cause a significant fraction of cancer related fatalities in the United States, 
with 14,080 deaths and 61,560 new cases estimated in 2015 (1, 2). Approximately 90% of 
kidney cancers arise from the renal parenchyma and are termed renal cell carcinomas (RCC)
(2). RCC has been differentiated from normal tissue based on epigenetic (3, 4), genetic (5), 
proteomic (6–8), metabolomic (9, 10), and lipidomic markers (11, 12). While these 
techniques are highly informative, analysis time is generally incompatible with 
intraoperative application, which is the long-term objective of this study. Ambient ionization 
mass spectrometry (MS), the MS analysis of samples in their native environment with little 
or no sample preparation, may improve surgical outcomes by providing surgeons with 
information that helps determine tissue disease state and identifies the tumor margin on the 
time scale of surgery. Previous intraoperative and/or ex vivo results from several 
investigators for brain (13–16), colon, lung, and liver (17, 18) cancers support this 
expectation. Moreover, it is known in several cancers that phospholipid profiles differ 
between tumor and normal tissues (19–21). Lipids have been explored for recognizing 
cancerous tissue using a variety of ambient ionization techniques such as touch spray (TS)
(22), probe electrospray ionization (PESI)(23), rapid evaporative ionization (REIMS)(17), 
and desorption electrospray ionization (DESI)-MS(24). Lipids are of interest because of 
their roles in cell signaling, cell-cell recognition, immune response, energy metabolism, the 
malignant transformation of cells (25–27), and are expected to be reflective of disease state.
TS-MS involves the physical sampling of tissue using a metallic probe with subsequent 
ionization occurring directly from the probe upon the addition of solvent (1–2μL) and high 
voltage (4 – 5kV) (see Electronic Supplementary Material Fig. S1)(22, 28). Free fatty acids 
and glycerophospholipids, including phosphatidylcholines (PCs) and phosphatidylinositols 
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(PIs), are typically detected when performing TS-MS on frozen tissue sections (28). TS-MS 
was previously used to analyze frozen sections of prostate cancer specimens from 18 human 
subjects, differentiating between normal prostate and prostate cancer (22). However, TS-MS 
has not been used to study fresh in vitro tissue in a way that emulates possible intraoperative 
use. Like TS-MS, PESI-MS is an ambient ionization technique that uses a conductive 
metallic probe to sample tissue by puncturing it and then creating ions directly from the 
probe by application of high voltage (23, 29). Yoshimura et al. analyzed fresh human RCC 
specimens with PESI in the positive ion mode, and observed differences from normal tissue 
in phosphatidylcholine and triacylglycerol profiles (11). PESI has also been used to analyze 
chemically induced hepatocellular carcinoma in a live mouse mounted on a sampling stage 
positioned in front of a mass spectrometer (30). PESI and TS are both invasive techniques, 
but only small amounts of material (10–100 micrograms) are required to generate data. Both 
these techniques balance speed of analysis, degree of invasiveness, and amount of sample 
preparation such that they are amenable to intraoperative applications. An alternative 
technique, REIMS, samples ions directly from the surgical smoke produced by 
electrocauterization (17, 18, 31). REIMS is a fast method because the surgical removal of 
tissue and mass spectrometric sampling are performed nearly simultaneously; however, the 
data are harder to correlate with traditional histopathology, the gold standard for diagnosis.
DESI-MS is a microprobe experiment in which a charged aerosol is sprayed onto a sample 
(e.g. a tissue section or smear) with a spot size of around 200μm. The resulting thin liquid 
film formed on the sample surface dissolves some compounds, and subsequent droplet 
impacts produce splashes of charged, analyte containing microdroplets. Gas-phase ions are 
generated via electrospray like processes when the secondary microdroplets are sampled by 
the mass spectrometer (32). DESI-MS imaging (DESI-MSI) experiments are performed by 
rastering the spot across the sample in a controlled fashion. An advantage of DESI-MSI 
when using an appropriate solvent is that the analyzed tissue can be stained with 
haematoxylin and eosin (H&E) subsequent to MS analysis and evaluated by histopathology, 
enabling direct correlations to be drawn between molecular and morphological information 
(33). DESI-MSI has been applied to analyze several malignancies (20, 21, 34, 35), including 
kidney cancers (12, 36), and demonstrated that the detected ions were reliably indicative of 
disease state (viz. distinction between tumor and normal) via multivariate statistics. Finally, 
although not an ambient ionization technique, matrix assisted laser desorption ionization 
(MALDI) mass spectrometry has been performed in an imaging format and it can also be 
used to profile tissue specimens, but the technique requires additional sample manipulation 
and it takes longer to analyze biopsy specimens (37–39).
In this study, TS-MS was used to analyze fresh healthy renal tissue and RCC specimens. As 
a reference method, DESI-MSI was performed following TS-MS analysis because DESI has 
been studied in more detail (DESI was first used to analyze tissue sections in 2005 (24), and 
TS was developed in 2014 (28)), and because measured DESI-MS lipid profiles can be 
precisely correlated with histopathological information by staining the analyzed tissue after 
DESI-MSI. Previous DESI-MSI studies of RCC in the negative ionization mode indicated 
the ability to differentiate RCC and healthy renal tissue with multivariate statistics, including 
the ability to differentiate clear cell renal cell carcinoma (ccRCC) and papillary RCC (12). 
Based on this previous work, we chose to perform the data acquisition in the negative 
Alfaro et al. Page 3
Anal Bioanal Chem. Author manuscript; available in PMC 2017 August 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
ionization mode. This study focuses on the rapid analysis of fresh renal tissue using TS-MS 
with supporting DESI-MSI analysis.
 Materials and Methods
 Tissue Handling
All tissues samples were acquired from patients undergoing nephrectomy (partial or radical) 
for the treatment of RCC and were handled in accordance with approved Institutional 
Review Board (IRB) protocols at Indiana University School of Medicine (1205008669) and 
Purdue University (1203011967). A small portion (approximately 3 × 3 × 3 mm) of tumor 
and adjacent normal kidney tissue was taken from the biopsy in the pathology lab 
(University Hospital, Indianapolis) and analyzed on site using TS-MS. TS-MS analysis was 
performed while the tissue was fresh (not frozen or fixed). Subsequent to TS-MS analysis, 
the biopsy specimens were snap frozen in liquid N2 and transported back to Purdue 
University on dry ice for DESI-MSI analysis. Tissue samples were obtained from 21 
subjects over the period of one year. Of the 21 cancer subjects, there were 15 clear cell RCC, 
two papillary RCC, and three unclassified RCC, as well as one oncocytoma (see Table S1).
 TS-MS Analysis of Freshly Resected Kidney Tissue
On each day of surgery, the pathology laboratory at University Hospital notified the Purdue 
researchers when tissue was acquired from the operating room. The researchers transported 
the tissue specimens from the pathology laboratory to the LTQ mass spectrometer (Thermo 
Scientific, San Jose, CA) located in an adjacent research building. TS-MS was performed on 
the fresh (not frozen or fixed) tissue specimens using a metal teasing needle purchased from 
Fisher Scientific (Pittsburgh, PA, USA) to scrape small amounts of cellular material from the 
bulk tissue (22). The probe was positioned in front of the mass spectrometer with the metal 
tip pointing at the inlet (~5–8 mm) a high voltage (4 kV) was applied and a 1 μL aliquot of 
methanol was added to initiate ionization. Data were collected over the range m/z 200–1000 
in the negative ionization mode. A chronogram showing the time dependence of a typical 
TS-MS signal recorded from a single solvent addition is shown in Electronic Supplementary 
Material Fig. S2. After TS-MS analysis at IUSM, the tissue specimens were snap frozen in 
liquid nitrogen to preserve morphology and halt biochemical processes. The samples were 
then transported to Purdue for subsequent cryosectioning and DESI-MSI analysis. 
Parameters for MS/MS experiments which used an LTQ mass spectrometer and exact mass 
measurements using an Orbitrap (Thermo Exactive, San Jose, CA), as well as additional 
methods on data handling, are provided in the Electronic Supplementary Material.
 DESI-MS Analysis of Frozen Tissue Sections
At Purdue, samples from each case were embedded in Optimal Cutting Temperature 
polymer (Sakura Finetek, Torrance, CA) and sectioned on a cryotome FSE to 10 μm 
thickness and thaw mounted on glass slides (Gold Seal UltraFrost Frosted Slides, Thermo 
Scientific, San Jose, CA). Tumor and normal specimens (as determined by gross analysis 
performed in the pathology lab at IUSM) from each case were thaw mounted adjacent to 
each other on the same glass slide. A custom-built DESI source, similar to the DESI 2D 
Source available from Prosolia Inc. (Indianapolis, IN), was used to image the tissue (40). 
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DESI spray solvent of dimethylformamide(DMF)-acetonitrile(ACN) 1:1 was used to 
minimize alteration of tissue morphology (33). Additional DESI imaging and sample 
handling parameters are provided in the Electronic Supplementary Material. MS data were 
recorded over the range m/z 200–1000 in the negative ion mode, automatic gain control 
(AGC) was turned off, and data acquired in the profile mode. The tissue sections were 
stained with H&E after DESI-MSI. A pathologist (L.C.) determined regions of healthy renal 
tissue and RCC. The DESI imaging data were compiled into a data cube using an in-house 
program. Data format was compatible with BioMap software (free to download http://
www.imzml.org/index.php?option=com_content&view=article&id=14&Itemid=32). 
BioMap was used to extract mass spectra from regions of interest (ROIs) representing RCC 
and healthy renal tissue based on the histopathological examination (see Fig. S3).
 Histological and Pathological Data
The pathology lab at IUSM performed histopathologic analyses on the remaining tissue after 
providing the specimens to researchers as discussed. The pathologic status of the adjacent 
tissue, as well as the histologic subtype, both determined by the pathology lab at IUSM, was 
used to correlate disease status with TS-MS lipid profiles. De-identified clinical and 
pathological data are provided in Electronic Supplementary Material Table S1. In addition, 
the tissue sections analyzed by DESI-MSI were subsequently stained with H&E and 
interpreted by a pathologist (L.C.) to determine regions of healthy tissue and RCC.
 Statistical Analyses of Mass Spectrometry Data and Data Visualization
Principal component analysis (PCA), using the non-linear iterative partial least squares 
algorithm, on the TS-MS and DESI-MSI data was performed using MATLAB (MathWorks, 
Natick, MA) and in-house routines which were described in previous work (41). Data were 
normalized using standard normal variate transforms to correct for baseline shifts and global 
variation in signal intensities. While data were recorded over the range m/z 200–1000, only 
m/z 700–1000 was utilized for PCA and subsequent linear discriminant analysis (LDA), as 
this mass range provides better diagnostic information(35). LDA on the PCA compressed 
data was performed in MATLAB to discriminate between healthy renal tissue and RCC (42). 
PCA-LDA was used to calculate sensitivity (true positive rate) and specificity (true negative 
rate) by means of cross validation (using n=5 deletion groups, Table S2). This procedure is 
described in detail elsewhere (43). The dispersion in relative ion intensity for a few ions was 
plotted as box and whisker plots using OriginPro 2016 (OriginLab, Northampton, MA). 
Unpaired two sample T-tests of unequal variance and Kruskal-Wallis non-parametric tests 
were performed in OriginPro 2016 using the raw, unnormalized signal intensities (Table S3).
 Results and discussion
Principal component analysis (PCA) was performed on TS-MS data after standard normal 
variate (SNV) normalization and mean-centering. The PCA score and loading plots are 
shown in Fig. 1A and 1B, respectively. Separation between RCC and healthy renal tissue is 
observed in the score plot. As seen in the loading plot (Fig. 1B), healthy renal tissue is more 
abundant in m/z 794 and 792 (tentatively identified as chlorinated adducts of PC 34:1 and 
PC 34:2, respectively), and RCC is more abundant in m/z 844 and 885 (tentatively identified 
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as chlorinated PC 38:4 and deprotonated PI 38:4, respectively). These assignments are from 
MS/MS spectra of these ions, as well as exact mass data, which are shown in electronic 
supplementary material Figs. S4&5. The increased abundance of PI 38:4 in tumor cells is 
supported by biochemical studies from other laboratories which observed that altered 
inositol phospholipid metabolism as a common downstream effect due to the activation of 
several oncogenes including src, met, trk, mos, raf, and ras (25, 44). Differences in m/z 
abundances are apparent in the average mass spectra of healthy renal tissue and RCC shown 
in Figs. 1C and 1D, respectively. Cross validation of a discriminant model, linear 
discriminant analysis (LDA) on the PCA compressed data, was performed. The average 
sensitivity (true positive rate) was 98.7% and specificity (true negative rate) was 94.6% 
using five deletion groups and five principal components. The preliminary sensitivity and 
specificity results are encouraging and they warrant further investigations with larger sample 
sizes to establish and validate the method’s diagnostic capabilities. Additional PCA score 
and loading plots are shown in Fig. S6, and confusion matrices for the cross validation are 
shown in supplemental Table S2. The importance of additional ions in separating RCC from 
healthy renal tissue can be appreciated by examining the lower-order PCA score and loading 
plots shown in Fig. S6; additional information on interpreting PCA score and loading plots 
can be found in Pirro et al (41). The univariate statistical significance of several of these 
ions, including m/z 771, 788, 792, 794, 810, 816, 844, and 885, in differentiating tumor and 
normal was evaluated with an unpaired two sample T-test of unequal variance and a Kruskal-
Wallis non-parametric test (Table S3), as well as being visualized with box and whisker plots 
(Fig. S7). Agreement was observed between the univariate tests for all tested m/z values. 
The p-value was <0.05 for each of the eight ions except for m/z 844 in which the null 
hypothesis (the mean value of each dataset originates from the same distribution) failed to be 
rejected.
Histopathologic subtypes of the specimens were provided by the IUSM pathology lab, and 
additional PCA score and loading plot as well as average mass spectra are provided in 
Electronic Supplementary Material Fig. S8. The number of samples in each subtype was too 
small to comment on the ability of TS-MS to delineate RCC subtypes. Subtyping is a topic 
worth exploring further but is beyond the scope of this communication.
The results from the DESI-MSI experiments, used as a reference method to compare with 
the TS-MS results, are shown in Fig. 2. Similar but better separation is observed in the 
DESI-MSI PCA score plot (Fig. 2A); however, the DESI loading plot (Fig. 2B) is 
characterized by m/z 788 and 810 (tentatively deprotonated PS 36:1 and PS 38:4, 
respectively) and the same TS ion m/z 885 (deprotonated PI 38:4). These ions (m/z 788,810, 
and 885) are evident in the averaged spectra for RCC and healthy renal tissue shown in Fig. 
2C and 2D. The significant contribution of m/z 810 is also observed in the TS-MS data in 
PC5 (see electronic supplementary material Fig. S6E&F). Examples of H&E stained tissue 
sections after DESI-MS analysis as well as a selection of DESI-MS ion images for 
specimens from three subjects are shown in Fig. S9. Additional PCA score and loading plots 
for the DESI-MS data are shown in Fig. S10. Cross validation was performed on the DESI 
PCA-LDA model in a fashion similar to the TS datasets. Using five deletion groups and 
three principal components, the average sensitivity was 100% and specificity was 88.9% 
(Table S2). The difference in abundance of the type of ion detected (i.e. chlorinated adduct 
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vs. deprotonated molecule) between TS and DESI can be attributed simply to differences in 
ionization mechanisms, increased biofluid content in the fresh tissue analyzed by TS-MS, 
and perhaps to the use of different spray solvents (methanol for TS and 1:1 DMF-ACN for 
DESI)(28, 33). Relative to DESI, the greater contribution of chlorinated adducts in TS-MS is 
a previously reported phenomenon (28). The difference between DESI and TS mass spectra 
suggest that future uses of TS as a diagnostic method will require the development of 
spectral databases (training sets) composed of TS-MS data.
The reported data suggest that TS-MS has the potential to yield diagnostic chemical 
information from fresh healthy renal tissue and RCC tissue. Prior to undertaking a large-
scale study, a TS-MS ionization source equipped with microcontrollers for precise probe 
manipulation and an automated solvent delivery system should be designed and optimized to 
increase data quality and reproducibility. While the TS-MS experiments were conducted on 
tissue after resection from a human subject, the analysis occurred on the intraoperative 
timescale. The results support larger scale studies of ex vivo surgical tissue using TS-MS to 
generate a comprehensive database of RCC specimens.
Additional aspects worth investigating are tumor heterogeneity and tumor margins. Ideally, 
the short analysis time and minimal invasiveness of TS-MS suggest that it might be used to 
profile various regions within the tumor mass itself and in the surrounding parenchyma. It 
would be interesting to investigate how the TS-MS lipid profiles (e.g. molecular 
information) vary within the tumor, as it has been shown that the extent of tumor 
heterogeneity is underestimated because of limitations in the number of samples that can be 
obtained (45, 46). Additionally, TS-MS may aid in delineation of the tumor-parenchyma 
margin (i.e. tumor margin) in partial nephrectomies, as the utility of intraoperative frozen 
section analysis remains controversial (47). This would be beneficial because negative 
parenchymal surgical margins of any size (e.g. less than 1mm) for localized, low grade (T1) 
RCC have been shown to result in virtually 0% recurrence of the disease (48, 49).
 Conclusions
This preliminary study demonstrated the feasibility of TS-MS analysis on a small number of 
fresh ex vivo surgical tissue specimens, as an intermediate step between frozen tissue 
analysis and intraoperative analysis. TS-MS differentiation of specimens using PCA and 
LDA was demonstrated, and the ions of greatest importance for separation were tentatively 
identified as complex membrane phospholipids m/z 794 (PC 16:0_18:1), 885 (PI 38:4), and 
844 (PC 38:4). DESI-MS differentiation of RCC and normal specimens was readily 
achieved by TS-MS and DESI-MS although different ions were important for separation 
between the two methods. Future work aims to expand the number of specimens in order to 
validate diagnostic capabilities, and further study the analytical figures of merit of the TS-
MS methodology. The applicability of the technique is likely not exclusive to renal cell 
carcinomas, and it would be fruitful to investigate TS-MS in other cancers. In addition, 
refinements to the TS-MS methodology should be pursued to increase the ruggedness, ease 
of use, accuracy, and reproducibility of the measurements.
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 Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. 
Negative ion mode TS-MS results from the kidney surgical cases. A) PCA score plot of the 
TS-MS data. Each object represents a separate sampling-ionization event from the freshly 
resected tissue. Healthy renal tissue is blue, RCC is red. A total of 18 human subjects are 
represented, with 16 RCC and 13 healthy renal tissue specimens, respectively. The average 
sampling events per tissue is five. B) Corresponding PCA loading plot showing that m/z 792 
([PC 34:2 + Cl]−), 794 ([PC 34:1 + Cl]−), 844 ([PC 38:4 + Cl]−), and 885 ([PI 38:4 - H]−) 
are the major contributors to the separation observed in A. C and D) Average mass spectra 
of the normal and tumor classes, respectively. The SNV normalized signal intensity is 
plotted in the average spectra.
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Fig. 2. 
Negative ion mode DESI-MSI results from the surgical kidney specimens. DESI-MSI on 
cryosectioned tissue was conducted after the TS-MS analysis on the fresh tissue. Samples 
from 20 human subjects are presented, with 16 RCC and 15 healthy renal tissue specimens, 
respectively. A) The PCA score plot of the DESI-MSI data. Each object represents a mass 
spectrum obtained from a ROI of a single tissue specimen. Healthy renal tissue is blue, RCC 
is red. B) The corresponding loading plot for the score plot in A, showing contributions of 
m/z 788 ([PS 36:1-H]−), 810 ([PS 38:4-H]−), and 885 ([PI 38:4 - H]) in the separation 
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observed in the score plot. C & D) The SNV normalized average DESI mass spectra of the 
healthy renal tissue and RCC classes, respectively.
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